BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37191188)

  • 21. Effectors and effects of arginine methylation.
    Wang Y; Bedford MT
    Biochem Soc Trans; 2023 Apr; 51(2):725-734. PubMed ID: 37013969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Study of
    Lorenzon L; Quilles JC; Campagnaro GD; Azevedo Orsine L; Almeida L; Veras F; Miserani Magalhães RD; Alcoforado Diniz J; Rodrigues Ferreira T; Kaysel Cruz A
    ACS Infect Dis; 2022 Mar; 8(3):516-532. PubMed ID: 35226477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity.
    Ratovitski T; Jiang M; O'Meally RN; Rauniyar P; Chighladze E; Faragó A; Kamath SV; Jin J; Shevelkin AV; Cole RN; Ross CA
    Hum Mol Genet; 2022 May; 31(10):1651-1672. PubMed ID: 34888656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
    Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
    Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy.
    Dai W; Zhang J; Li S; He F; Liu Q; Gong J; Yang Z; Gong Y; Tang F; Wang Z; Xie C
    Front Immunol; 2022; 13():865964. PubMed ID: 35493527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer.
    Shailesh H; Zakaria ZZ; Baiocchi R; Sif S
    Oncotarget; 2018 Nov; 9(94):36705-36718. PubMed ID: 30613353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth.
    Li WJ; He YH; Yang JJ; Hu GS; Lin YA; Ran T; Peng BL; Xie BL; Huang MF; Gao X; Huang HH; Zhu HH; Ye F; Liu W
    Nat Commun; 2021 Mar; 12(1):1946. PubMed ID: 33782401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein arginine methyltransferases: promising targets for cancer therapy.
    Hwang JW; Cho Y; Bae GU; Kim SN; Kim YK
    Exp Mol Med; 2021 May; 53(5):788-808. PubMed ID: 34006904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRMT-5 converts monomethylarginines into symmetrical dimethylarginines in Caenorhabditis elegans.
    Kanou A; Kako K; Hirota K; Fukamizu A
    J Biochem; 2017 Feb; 161(2):231-235. PubMed ID: 28173048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
    Krause CD; Yang ZH; Kim YS; Lee JH; Cook JR; Pestka S
    Pharmacol Ther; 2007 Jan; 113(1):50-87. PubMed ID: 17005254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer synthetic vulnerabilities to protein arginine methyltransferase inhibitors.
    Guccione E; Schwarz M; Di Tullio F; Mzoughi S
    Curr Opin Pharmacol; 2021 Aug; 59():33-42. PubMed ID: 34052526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Protein Arginine Methyltransferases in DNA Damage Response.
    Brobbey C; Liu L; Yin S; Gan W
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein Arginine Methyltransferases in Cardiovascular and Neuronal Function.
    Couto E Silva A; Wu CY; Citadin CT; Clemons GA; Possoit HE; Grames MS; Lien CF; Minagar A; Lee RH; Frankel A; Lin HW
    Mol Neurobiol; 2020 Mar; 57(3):1716-1732. PubMed ID: 31823198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptidic transition state analogues as PRMT inhibitors.
    Zhang Y; van Haren MJ; Martin NI
    Methods; 2020 Mar; 175():24-29. PubMed ID: 31421210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
    Hu H; Luo C; Zheng YG
    J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arginine Methylation: The Coming of Age.
    Blanc RS; Richard S
    Mol Cell; 2017 Jan; 65(1):8-24. PubMed ID: 28061334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A patent review of arginine methyltransferase inhibitors (2010-2018).
    Li X; Wang C; Jiang H; Luo C
    Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells.
    Szewczyk MM; Vu V; Barsyte-Lovejoy D
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34424246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Arginine Methyltransferase Product Specificity Is Mediated by Distinct Active-site Architectures.
    Jain K; Warmack RA; Debler EW; Hadjikyriacou A; Stavropoulos P; Clarke SG
    J Biol Chem; 2016 Aug; 291(35):18299-308. PubMed ID: 27387499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical Roles of Protein Arginine Methylation in the Central Nervous System.
    Chang K; Gao D; Yan J; Lin L; Cui T; Lu S
    Mol Neurobiol; 2023 Oct; 60(10):6060-6091. PubMed ID: 37415067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.